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One ofthe most fundamental questions remaining incellularimmunology is how
the repertoire of antigen-specific T cell receptors is selected to recognize foreign
antigens in association with the glycoproteins encoded by the MHC. The receptor
on T cells is composed oftwo disulfide-linked variable chains, called a anda, and
is associated with an invariant complex ofproteins called CD3 (1-5). A single a/(3
heterodimer is known to confer both antigen and MHC recognition specificity to
an individual T cell (6, 7), with most CD4+ CD8- T cells using class II, and
CD4-CD8+ T cells using class I MHC molecules as recognition elements (8). T
cells recognize antigens together with those MHC glycoproteins that they have en-
countered during theirdevelopment rather than their own geneticallyencoded MHC
products. This remarkable phenomenon, known as MHC-restricted recognition,
is established in the thymus through a not yet fully defined selection process. One
modelused to describe this process, termed "positive selection,"argues that only those
T cells with sufficient avidity for the MHC glycoproteins expressed in the thymus
are "positively selected," i.e., allowed to acquire functional maturity and to be ex-
ported to the periphery (9-12). More recent variants ofthis model propose that the
selectionprocessdoesnot, infact, involve"naked" MHC molecules, but rather thymic
MHC complexed to acollection ofself-peptides (13-16), possibly uniquely expressed
on certain thymic stromal cells.
Much ofthe evidence supporting thepositive selection model stems from studies
with thymus-engrafted hemopoietic chimeras, which, given thecomplexities ofsuch
experimental systems, have generated muchcontroversywith respectto this hypoth-
esis (reviewed in references 17, 18). For this reason, a particular aim of our studies
hasbeen toexaminethe issueofthymic selectionwithexperimental systemsentirely
different from chimeras. In the present paper, we examine the T cell repertoire
specificities ofCD4-CD8+ cytotoxic T cells developing under conditions where one
ofthe classI MHC-encoded moleculesisblocked bytreatmentfrom birthwithspecific
mAbs, while other class I MHC glycoproteins are still expressed. We show that in
each experimental system used, antigen-specificT cellsrestricted to the blocked class
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I fail to develop, while generationofother class I-specific T cells proceeds undisturbed.
These data provide strong support for the notion that the thymic MHC selection
element and the T cells' MHC restriction element are one and the same, and are
consistent with the recent evidence for positive selection in anti-class II mAb-treated
mice (19) and TCRot//3 transgenic mice (20-22). Together, these results demonstrate
that one ofthe crucial interactions required for the intrathymic selection ofthe reper-
toire ofTCR specificities is that between the TCR and MHC or some form ofMHC.
Materials and Methods
Mice andIn Vivo mAb Treatments.
￿
All mouse strains were either bred at the Frederick Cancer
Research Facility or obtained from the Jackson Laboratory, Bar Harbor, ME. Neonatal mice
were treated within 24 h of birth with anti-H2-Kk rnAb (hybridoma 11-4.1, reference 23, ob-
tained from the American Type Culture Collection, Rockville, MD), purified from ascites
as described (24). Mice were injected daily intraperitoneally with 50014g per gram body weight
and analyzed when 2-3 wk old. Control mice were treated daily with saline, and other rele-
vant controls were as previously described (25).
Flow Cytometry Analysis.
￿
Analysis was performed as described earlier (24), using a B-D
Dual Laser FACS 440 interfaced to a PDP 11/24 computer. Data were collected on 50,000
viable cells (as determined by forward light scatter and propidium iodide gating) and dis-
played either as contour diagrams (Figs. 1 and 2), with a 3-decade log scale of increasing
green fluorescence on the x-axis and red fluorescence on the y-axis, or as histograms with
a 3-decade log scale ofincreasing green fluorescence on the x-axis, versus relative cell number
(Fig. 3). In contour diagrams, the x- andy-axis coordinates that defined negative cells were
selected as the intersection of positive and control negative profiles in each parameter. mAbs
used for staining were: FITC-conjugated anti-CD8 or biotin-conjugated anti-CD8 (53.6 mAb;
Becton Dickinson & Co., Mountain View, CA); biotin-conjugated anti-CD4 (GK1.5 mAb;
reference 26); FITC-conjugated anti-CD3 (145-2Cll, reference 27); FITC-conjugated anti-
Kk (11-4.1, reference 23); FITC-conjugated anti-Dd (34-1-2, reference 28); and, as negative
controls, FITC- or biotin-conjugated anti-human Leu-2 (Becton Dickinson & Co.). Binding
of biotin-conjugated reagents was visualized with streptavidin-allophycocyanin.
Limiting Dilution Analysis of Cytotoxic T Cell Precursor Frequencies.
￿
Groups of 48 replicate
microcultures ofvarious numbers ofcontrol and treated responder cells were cultured in round-
bottomed wells of96-well microtiter plates in a final volume of0.2 ml of Eagles Hanks' amino
acid medium with 10% FCS, 2 MM L-glutamine, 5 x 10-5 M 2-ME, and 20% delectinated
rat Con A supernatant (Collaborative Research Inc., Bedford, MA). Stimulator cells were
5 x 105 irradiated (2,000 rad) spleen cells from 2-6-mo-old mice, either allogeneic to the re-
sponder cells or autologous and modified with 0.1 mM trinitrobenzenesulfonate (TNBS)'
according to earlier described procedures (29, 30). After 7 days ofculture, 103 5'-Cr-labeled
target cells were added per well; plates were incubated for 6 hrs, and centrifuged; 0.15 ml
of supernatant was removed from each well, and radioactivity of the samples was measured
in a gamma counter. Target cells were either tumor cells, for allogeneic responses (i.e., RDM4,
H-2k; EL-4, H-26
, P815, H-2d), or autologous Con A blasts, for TNP-specific responses,
modified with 10 mM TNBS. Positive wells were defined as those in which "Cr-release ex-
ceeded the mean of control wells in which target cells were incubated with stimulator cells
alone by more than 3 SD of the mean. Precursor frequencies were calculated as described
(24, 31) . When responder cells were thymocytes, mice had been pretreated at 24 and 48 h
before sacrifice with 1 mg hydrocortisone acetate, to enrich for CTL precursors (31).
Results
Kk Expression Is Requiredfor Generation ofKk-restricted CTL.
￿
In previous studies, we
showed that mice chronically treated with anti-class I mAb specific for both K- and
1 Abbreviations used in this paper: FCM, flow cytometry; LD, limiting dilution; TNBS, trinitroben-
zenesulfonate.MARUW-GALEW ET AL .
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D-encoded MHC gene products fail to develop the CD4-CD8 +-subset of T cells
that is responsible for class I-restricted cytotoxicT cell responses (25) . We next ex-
amined CD4 -CD8 + T cell development in mice in which only one of the class I
molecules, those encoded for by the MHC K region gene, was blocked . C3H (H-
2k) mice were treated from birth with anti-KkmAb (23) in daily doses sufficient to
block most of the Kk molecules on spleen andthymus cells, as judged by flow cytom-
etry (FCM ; data not shown; see Fig . 3 for B10.A (H-2a) mice). Two-parameterFCM
analysis with anti-CD4 and anti-CD8 mAbs revealed no differences between the
majorT cell subsets of control and treated mice (Fig. 1) . Thus, anti-K region mAb
treatment does not interfere with the overall development of CD4-CD8+ T cells,
or other T cell subsets .
We next investigated the ability of anti-class I K region antibody-treated mice
to generate CTL responses to allogeneic and TNP-modified syngeneic stimulator
cells. In this latter response, separate populationsofCTL specific forTNP in associ-
ation with eitherKor D region-encoded gene products are generated, and different
mouse strains exhibit preference forusing eitherK orD gene products as restriction
elements (29, 30). To verify applicabilityofthese rules in the limiting dilution (LD)
system required for ourCTL function analysis (25), we compared theCTL precursor
frequency ofTNP-specific CTL in different mouse strains (Table I) . Consistent with
earlier observations (29), H-2k and H-2a mice respond preferentially to K'--TNP,
H-2d mice respond preferentially to DdTNP, while (H-2k x H-2d)Fl mice exhibited
preferential K'-TNP responses when activated with K'-expressing stimulator cells,
and DdTNP responses when activated withKd Dd-stimulator cells (Table I) . These
FIGURE 1 .
￿
Effect ofin vivo an-
ti-class I (Kk) treatment on T
cell subsets in spleen (top) and
thymus (bottom) . C3H (H-2 k)
mice were treated from birth
with saline (left) or anti-Kk
mAb (11-4.1 ; right) and analyzed
when 3 wk old. Spleen and thy-
mocytes were reacted first with
FITC-conjugated anti-CD8
mAb, followed by biotin-conju-
gated anti-CD4 mAb, followed
by streptavidin-allophycocya-
nin. The proportions ofCD4-
CD8' T cells are : for control
spleen, 3.5; for treated spleen,
2.9 ; for control thymus, 2 .4 ; for
treated thymus, 2.2 . The
proportions of CD4' CD8-T
cells are : for control spleen, 9.3 ;
for treated spleen, 8.6 ; for con-
trol thymus, 11.2 ; for treated
thymus, 11.4 . Data canbe com-
pared to those for C3H mice
treated with anti-Kk-plus-Dk
mAb that were previously pub-
lished (25).1622
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' Reciprocal of CTL precursor frequency.
TABLE I
1/Frequency of CTL Precursors on Various TNP Targets
differenceswere not related tonon-MHC genes (datanot shown), ascongenic mouse
strains with MHC-differences alone yielded identical results (29).
To determine how anti-K' treatment affected the preferential KkTNP response
in H-2k Mice, the TNP-specific CTL responses ofspleen cells and thymocytes from
control and treated mice were compared. The results clearly demonstrate a marked
decrease in the precursor frequency of both splenic and thymic KkTNP-specific
CTL (Table 11). This decrease is not accompanied by a rise in the DkTNP-specific
CTL response, as evidenced by the failure, under any circumstances, to lyse Kd Dk
target cells (Table 11). Additionally, the CD4-CD8' T cells present in these mice
(Fig. 1) were demonstrated to be functional, in that normal alloreactive CTL re-
sponses to H-2n and H-2d stimulator cells were generated (Table 11). Also, exami-
nation ofTCR expression by two-parameter FCM analysis with a mAb specific for
the murine CD3-e chain (27) versus anti-CD4 oranti-CD8 staining(Fig. 2) revealed
no discernable differences between T cells from control and treated mice.
To address whether the selective inhibition of K'-TNP-specific responses could
be due to anti-K' mAb carried over into the culture, we examined the TNP-specific
TABLE II
In H-2~ Mice Treated from Birth with Anti-K* mAb, (TNP + K'1)-speck CTL Fail to Develop
' Exp. 1 : Responder spleen cells.
1 Exps. 2 and 3 : Responder thymocytes (cortisone resistant).
5 Reciprocal of CTL-precursor frequency.
Exp.
Responder
cells
Stimulator:
Targets: KkDk-TNP
C3H-TNP
KdDk-TNP KkDb-TNP
Stimulators: B6
Targets: B6
C3H
C3H
BALB/c
BALB/c
1' Control" 5,500 >200,000 10,000
Treated (1) 50,000 >200,000 >100,000 NT
Treated (2) >200,000 >200,000 >200,000
Treated (3) >200,000 >200,000 >200,000
21 Control 4,000 >100,000 3,500 2,500 >200,000 4,2005
Treated (1) >100,000 >100,000 >100,000 3,600 >200,000 7,000
Treated (2) >100,000 >100,000 >100,000 4,800 >200,000 3,000
31 Control 1,500 >100,000 2,000 1,000
Treated (1) >100,000 >100,000 >100,000 2,100
Treated (2) >100,000 >100,000 >100,000 2,400
Response
B10.A
KkDd
C3H
KkDk
C3H.OL
KdDk
BIO.A(2R)
KkDb
BALB/c
KdDd
136
KbDb
C3H-Anti-C3H (TNP) NT 4,000' >100,000 2,000 >200,000 >200,000
B10.A-Anti-B10.A (TNP) 12,000 10,000 >200,000 11,000 >200,000 NT
BALB/C-Anti-BALB/c (TNP) 10,000 >200,000 >200,000 >200,000 >11,000 NT
(C3H x BALB/c)
Fi-Anti-Fl (TNP) 9,000 8,000 >200,000 9,000 >200,000 >200,000
Anti-C3H (TNP) 8,000 7,500 >200,000 7,500 >200,000 >200,000
Anti-BALB/c (TNP) 10,500 >200,000 >200,000 >200,000 12,000 >200,000D
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TABLE III
Does Blocking Antibody Remaining on Responder Cells
(from In Vivo Treatment) Affect CTL Responses?
FIGURE 2. Effect of in vivo
anti-class I (Kk) treatment on
TCRexpression in spleen cells.
C3H (H-2k) mice were treated
from birth with saline (left) or
anti-Kk mAb (11-4.1; right) and
analyzedwhen 3 wkold. Spleen
cells were reacted first with
FITC-conjugated anti-CD3
mAb, followed bybiotin-conju-
gated anti-CD4 mAb (top) or
anti-CD8 mAb (bottom), followed
by streptavidin-allphycocyanin.
The proportions ofCD3'CD4-
CD8' T cells are: for control
spleen, 3.4; for treated spleen,
3.0; CD3'CD4'CD8- T cells;
for control spleen, 10.6; for
treated spleen, 11.3.
CTL response ofcells preincubated in anti-K' mAb under saturating conditions.
The results shown in Table III demonstrate that the K'--TNP response of H-2k cells
is not affected by anti-K'mAb on theresponder cells, making itunlikely that carry-
over of the mAb could account for the defect observed in anti-Kk-treated mice.
Taken together, these results therefore demonstrate that anti-Kk antibody treatment
ofH-2k mice selectively affected generation ofKk-TNP-specific CD4-CD8+ T cells,
while development ofother functional CD4-CD8+ T cells proceeded undisturbed.
Finally, we analyzed whether anti-Kk antibody-treated mice were still tolerant
for Kk. Spleen cells (Table II) or thymocytes (data not shown) of anti-Kk-treated
mice were stimulated with syngeneic or allogenic irradiated spleen cells in mixed
lymphocyte cultures. Clearly, neithercontrol nortreated cellsresponded with aCTL
response to stimulation with syngeneicstimulatorcells (Table II), whileboth responded
' Responder spleen cells.
1 Reciprocal of CTL-precursor frequency.
Response 1/Frequency of CTL precursors on various TNP targets
against
C3H-TNP
C3H
KkDk
C3H.0L
KdDk
B10.A (2R)
KkDb
B6
KbDb
C3H' 12,000 >100,000 18,000 >100,000
C3H coated
with anti-Kk 15,000 >100,000 20,000 >100,0001624
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equally well to stimulation with allogeneic stimulator cells. Thus, mice treated with
anti-K' were found to be tolerant for Kk, while they could not "positively select"
for K'-restricted CTL. To explain the failure to positively select, and the success
of tolerization in these mice, we invoke the following arguments: Since intrathymic
clonal deletion ofself-reactive cells(32-34) is thought to involvehigh-affinityinterac-
tions with predominantly bone marrow-derived cells (16, 35-37), it is possible that
Kk molecules on these cells were not completely blocked by the injected mAb. In-
deed, anti-Kk treatment did not saturate all Kk-molecules in thymus and spleen (see
Fig. 3 for B10.A mice; same results for other mouse strains), hence there may have
been sufficient Kk expression to allow for tolerization. Our data do not distinguish
what cells are not blocked by antibody treatment. Because positive selection would
involve interactions ofalower affinity (16), it should be easier to block positive selec-
tion than to block clonal deletion. Thus our data support these models of thymus
function involving self-restriction and self-tolerance.
Blocking ofKk Class I Molecules During Development ofthe T Cell Repertoire Interferes
with Generation of KkTNP-specific CTL, but not1)4-specific CTL. In the experiments
reported above, generation of K'-TNP-specific CTL was shown to require K'-
expression during development of the repertoire. These data would be consistent
with the positive selection theory, provided that it can be proven that K'-blocking
alone does not affect development of all TNP-specific responses. To check whether
any TNP-specific responses can be generated in anti-K'-suppressed mice, we next
examined the effects of Kk blocking in mice with a D region allele "permissive" for
TNP responses, i.e., B10.A and (C3H x BALB/c)Fi mice (see Table I).
As in the treated C3H (H-2k) mice, B10.A (H-2a) mice fail to generate Kk-TNP
responses when treated from birth with anti-Kk-mAb (Table IV). However, al-
though in BALB/c (H-2d) mice CTL exhibit the ability to recognize TNP in as-
sociation with Dd, no DdTNP responses are generated in the anti-Kk-suppressed
B10.A mice. We therefore examined whether B10.A mice treated with anti-Kk still
express Dd molecules. Since comodulation ofclass II (38) and class I glycoproteins
W
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￿
STARING FOR DO
THYMUS 101 .Y THYMUS
CONTROL
10970 green fluorescence
FIGURE 3. Effect of in vivo
anti-class I (Kk) treatment on
Kk andDd expression in B10.A
(KkDd) mice. BIO.A (H-2KDd)
mice were treated from birth
with saline (solid line)or anti-Kk
mAb (11-4.1; broken line), and
analyzed when 3 wk old for
expression of Kk (left) or Dd
(right). Spleen cells or thymo-
cytes were reacted either with
FITC-conjugated 11-4.1 mAb
(for Kk staining), or with
FITC-conjugated 34-1-2 mAb
CONTROL
￿
(for Dd staining). Negative
control staining(- .-. -) is shown
ANTI KK TREATED
￿
for only one of the samples in
each diagram, sincethesecurves
essentially overlapped.* All responder cells: cortisone-resistant thymocytes.
: Reciprocal of CTL-precursor frequency.
* All responder cells: cortisone-resistant thymocytes.
: Reciprocal of CTL-precursor frequency.
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TABLE IV
In BIO.A Mice (H-2 KkDd) Treatedfrom Birth with Anti-Kk mAb,
(TNP + Kk)-speck CTL Fail to Develop
(Ozato, K., personal communication) has been reported upon anti-MHC mAbtreat-
ment in vivo, the possibility that reduced Dd expression in anti-K'-treated BlO.A
mice was responsible for the failure to positively select Dd-restricted CTL had to
be considered. However, no evidence of comodulation Kk and Dd was found; Dd
expression is, at best, only slightly reduced in anti-K'-suppressed B10.A mice (Fig.
3), and identical results were obtained in (C3H x BALB/c)Fi mice (data not
shown). Thus, it appears that B10.A mice cannot generate DdTNP-CTL, despite
presence of the Dd restriction element during development.
At first sight, these data are at variance with the predictions of the positive selec-
tion theory: if the inability to generate K'-restricted responses in anti-K'-treated
mice is solely a reflection of a requirement for TCRKk interactions during devel-
TABLE V
In C3H x BALBlc Mice (H-2 KkDk x KdDd) Treatedfrom Birth with
Anti-Kk mAb, (TNP + Kk)-speck CTL Fail to Develop,
but (TNP + Dd)-speck CTL Do Develop
Responder Stimulator:
Exp. cells Targets: KkDk-TNP
KkDk-TNP
KdDk-TNP KkDd-TNP
1 Control* 2,500: >100,000 3,000
Treated (1) >100,000 >100,000 >100,000
Treated (2) 90,000 >100,000 >100,000
2 Control 3,300 >100,000 4,200
Treated (1) >100,000 >100,000 80,000
Treated (2) 85,000 >100,000 90,000
KdDd-TNP
KdDd-TNP KdDk-TNP KkDd-TNP
1 Control 6,000 >100,000 5,100
Treated (1) 6,600 >100,000 6,300
Treated (2) 11,000 >100,000 15,000
2 Control 19,000 >100,000 12,000
Treated (1) 11,000 >100,000 15,000
Treated (2) 12,000 >100,000 21,000
Responder
Exp. cells
Stimulator:
Targets: KkDd-TNP
KkDd-TNP
KdDd-TNP KkDd
Stimulator: B6
Target: B6
1 Control* 2,500: >100,000 >100,000 3,000
Treated >100,000 >100,000 >100,000 3,500
2 Control 2,400 >100,000 >100,000 1,000
Treated >100,000 >100,000 >100,000 2,1001626
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opment, remaining interactions between TCRs and Dd should still allow for devel-
opment ofDd-restricted TNP responses. Another strategy applied to address this
issue was the use of anti-K'-suppressed (C3H x BALB/c)Fj mice. In such mice
(see Table I), D'TNP-CTL responses can be generated, provided H-2dTNP stimu-
lator cells are used. Strikingly, anti-Kk treatment did not affect development ofDd-
TNP-CTL in the (C3H x BALB/c)Fj mice, as shown in Table V. The CTL
precursor frequencies generated upon stimulation with H-2dTNP stimulator cells
were very similar for treated and control mice, and responses mapped to Dd, as
shown by the absence oflysis when KdDkTNP target cells were used. At the same
time, anti-Kk-treated (C3H x BALB/c)Fi mice with unchanged DdTNP responses
exhibited very strongly reduced Kk-TNP responses, as shown in the top halfofTable
V. Thus, anti-Kk treatment leads, in three different mouse strains (CM, B10.A,
and [C3H x BALB/c]F1), to a failure to generate K'-restricted CTL specific for
TNP, while development of TNP-specific CTL using another restriction element,
i.e., Dd, is not affected in the strain combination where such responses are "per-
missive." These results directly demonstrate that generation of CD4-CD8' T cells
with restriction specificity for a certain class I molecule requires interactions with
that particular class I glycoprotein (or an unknown molecular complex containing
that particular class I glycoprotein), and thus support the positive selection theory.
Discussion
In a search for a direct test of predictions derived from the "positive selection"
theory, we analyzed the development ofclass I-restricted T cells under conditions
where particular class I glycoproteins were blocked by mAb treatment from birth
onward, while otherclassImoleculeswere unaffected. Clearly, theresults showthat,
in mice with blocked Kk molecules, there is a selective failure to develop only Kk-
restricted T cells, while other class I-restricted Tcells are generated undisturbed.
Thus, generation ofT cells with a particular TCR specificity isdependent on recog-
nition of a particular MHC glycoprotein during development, a result predicted
by the positive selection theory. These findings with anti-class I MHC mAb have
thereforeconfirmed thesuggestions madebystudies with hematopoietic andthymic
chimeras (9-12) and are consistent with the recent demonstration of positive selec-
tion in other anti-MHC mAb treatment studies (19, 39) and TCRa/O transgenic
mice (20-22). Thus, a role for TCRMHC interactions in the development of T
cells in normal mice has now been firmly established.
Although our studies describe whatwe assume tobe thegeneral situation inwhich
the thymic educatingelement (i.e., K') is identical to the T cells' restriction element,
there appear to be certain exceptions to this rule. Our experiments reveal an ex-
ample where theclass I education andclass I restriction element arediscordant from
each other. Under no circumstances could DdTNP CTL be generated from BIO.A
mice, i.e., a mouse strain expressing Dd glycoproteins. The explanation forthis ob-
servation is unclear. It is possible that the development of DdTNP CTL is depen-
dent on elements absent in B10.A, and present in BALB/c and (C3H x BALB/c)F1
mice. Alternatively, cells with TCRs specific for DdTNP could be deleted in B10.A
mice, but not in BALB/c and(C3H x BALB/c)Fi mice. Ifthe latter hypothesis were
correct, thedeletional elements would have to be non-MHC antigens, since allMHC
glycoproteins present in B10.A are also present in (C3H x BALB/c)Fi. Because ear-MARU9916-GALE916 ET AL.
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lier experiments (29, 30) demonstrated that the preferential Dd response was en-
tirely MHC linked, we favorthe first hypothesis, i.e., preferential differentiation of
DdTNP CTL under the influence of non-Dd MHC molecules in BALB/c and in
(C3H x BALB/c)Fj mice. Experiments are currently underway to evaluate the
mechanism ofthe generation ofDdTNP responses. Another example ofa Tcell's
reactivity and education element beingdisparate from each other canbe found among
T cells expressing a TCR with the V017a-0 chain. Such cells frequently recognize
various allelicforms ofthe I-E class II MHC molecule (32, 33), or, as more recently
proposed (40), different I-E-encoded glycoproteins complexed to a group of pep-
tides selectively expressed in some but not other cells. Either way, such I-E-reactive
T cells are generated in I-E- mouse strains such as SWR (33). Assuming that most
class II-specific T cells are dependent on class II expression during development
(24), wepredictthattheseI-E-reactiveT cellsare mostlikely positively selected through
interactions withI-A (atestable hypothesis). Nonetheless, whiletheseexamples serve
to illustrate that sometimes a dichotomy exists between the T cells' education and
restriction element, we predict that, as a general rule, the MHC element used for
positive selectionpredictsaTcell's restriction element. Without thisrule, there would
be no purpose for positive selection.
While the above data demonstrate that TCRMHC interactions provide signals
essential to the differentiation ofT cells, it is likely that the selection ofthe TCR
repertoire is additionally influenced byinteractionsotherthan those between TCRs
and their ligands. It was postulated earlier that the CD4 and CD8 accessory mole-
cules participate in the selection process (41), and more recent studies provide ex-
perimental support that this notion is correct, at least for negative selection (42,
43). Whether CD4 and CD8 molecules are also important participants in the pro-
cess ofpositive selection remains to be resolved. Blocking of MHC glycoproteins
during development may not only affect TCR-MHC interactions, as shown in the
present study, but also interfere with significant accessory molecule-MHC interac-
tions. In fact, it is conceivable that interactions between accessory molecules and
MHC glycoproteins otherthan thosebound by the TCR on developing T cells may
sometimes "skew" the developing repertoire, i.e., generate T cells whose MHC
specificity is disparate from the MHC molecules to which their receptors bound,
or delete T cells whose TCRs had insufficient affinity for the MHC on which they
were selected. Investigations ofdeveloping T cells underconditions where the acces-
sory molecules are blocked are currently underway. Whatever the outcome of such
experiments, the present results are not incompatible with an additional role for
accessory molecule-MHC interactions in development. At thesame time, however,
our results demonstrate that accessory molecule-mediated signaling alone is not
sufficient for generation of CD4-CD8+ T cells to occur. Instead, the findings sug-
gestthatTCRmediated events represent theprimary signals, i.e., whenthosesignals
are prevented, remaining CD8-mediated interaction are inconsequential. Clearly,
therefore, a crucial interaction that determines T cells' MHC restriction specificity
is between TCRs and MHC glycoproteins.
Summary
T cells recognize foreign antigens together with those MHC glycoproteins they
have encountered during their development in the thymus. How the repertoire of1628
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antigen-specific TCRs is selected has not yet been fully defined. We have investigated
the T cell repertoire specificities of CD4-CD8+ cytotoxic T cells developing under
conditions where one ofthe class I MHC-encoded molecules is blocked, while other
class I-MHC glycoproteins are still expressed. We show that antigen-specific T cells
restricted to the blocked class I fail to develop, while generation ofother class I-specific
T cells proceeds undisturbed. This highly selective perturbation ofthe T cell receptor
repertoire demonstrates that development of CD4-CD8 + T cells with a certain
TCR specificity requires expression ofparticular alleles ofclass I MHC. Thus, TCR
MHC interactions provide signals essential to the differentiation ofprecursor T cells.
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